Wilkerson Advisory Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.74K Sell
111
-62
-36% -$3.37K ﹤0.01% 499
2026
Q1
$10.9K Buy
173
+48
+38% +$3.84K ﹤0.01% 391
2025
Q4
$11.9K Buy
+125
New +$12.3K ﹤0.01% 309

Other funds holding BSX

Wilkerson Advisory Group's BSX Position: Q2 2026 in Review

Wilkerson Advisory Group reduced its Boston Scientific (BSX) stake by 36% in Q2 2026, selling an estimated $3.37K and leaving 111 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Wilkerson Advisory Group first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.9K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Wilkerson Advisory Group held 111 shares of Boston Scientific worth $4.74K as of Q2 2026.
  • Wilkerson Advisory Group sold 62 Boston Scientific shares in Q2 2026, an estimated $3.37K.
  • Boston Scientific made up ﹤0.01% of Wilkerson Advisory Group's portfolio in Q2 2026, its #499 holding.
  • Wilkerson Advisory Group first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Wilkerson Advisory Group's Boston Scientific position peaked at $11.9K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.